RxDoctor Payments Data

Tamara Patterson

Family · Emporia, KSNPI 1720350580

Payments from drug & device makers

$2,086in general payments, 2019–2025

Across 133 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$342
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$226
  • Novo Nordisk$180
  • AstraZeneca$151
  • Convatec Inc.$133
  • Merck$119
  • plus $935 from 21 others

What the payments were for

  • Food & beverage$2,086100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,086 in reported general payments places this provider in the 85th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide22$20,905
MounjaroTirzepatide18$18,127
JardianceEmpagliflozin19$15,476
OzempicSemaglutide16$14,819
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,836
Tresiba Flextouch U-100Insulin Degludec11$5,375
VascepaIcosapent Ethyl12$5,068
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$4,389
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen96$4,047
Celecoxib63$1,479
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen22$1,188
Duloxetine Hcl66$1,122
Albuterol Sulfate HfaAlbuterol Sulfate38$1,014
Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide34$1,005
Ezetimibe14$838

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$118$39,03240 claims
Boehringer IngelheimJardiance$79$15,47619 claims
Novo NordiskOzempic$180$14,81916 claims
AbbVieSynthroid$342$53915 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,579 family providers in Kansas.

Other family in Emporia

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →